| 1 |
35202484 | PharmVar GeneFocus: CYP3A5. | 2022 Feb 24 |
1 |
| 2 |
35629245 | Evaluation of Pharmacogenetics of Drug-Metabolizing Enzymes and Drug Efflux Transporter in Renal Transplants Receiving Immunosuppressants. | 2022 May 19 |
1 |
| 3 |
32162881 | Severe Anaphylaxis During Allogeneic Hematopoietic Stem Cell Transplantation in a Patient with Aplastic Anemia: Case Report of Individualized Pharmaceutical Care and Literature Review. | 2020 Mar 1 |
2 |
| 4 |
30378493 | Metabolic Pathway of Cyclosporine A and Its Correlation with Nephrotoxicity. | 2019 |
1 |
| 5 |
30520827 | Switching Immunosuppression From Cyclosporine to Tacrolimus in Kidney Transplant Recipients Based on CYP3A5 Genotyping. | 2019 Feb |
1 |
| 6 |
31385766 | Association Between CYP3A4 and CYP3A5 Genotypes and Cyclosporine's Blood Levels and Doses among Jordanian Kidney Transplanted Patients. | 2019 |
3 |
| 7 |
29113387 | Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients. | 2017 Oct 6 |
3 |
| 8 |
29135906 | Effect of Age and Allele Variants of CYP3A5, CYP3A4, and POR Genes on the Pharmacokinetics of Cyclosporin A in Pediatric Renal Transplant Recipients From Serbia. | 2017 Dec |
4 |
| 9 |
27310200 | Risk Assessment of Drug-Drug Interactions of Calcineurin Inhibitors Affecting Sirolimus Pharmacokinetics in Renal Transplant Patients. | 2016 Oct |
1 |
| 10 |
27653228 | Influence of Donor and Recipient CYP3A4, CYP3A5, and ABCB1 Genotypes on Clinical Outcomes and Nephrotoxicity in Liver Transplant Recipients. | 2016 Oct |
1 |
| 11 |
29441922 | The impact of CYP3A5 on the metabolism of cyclosporine A and tacrolimus in the evaluation of efficiency and safety of immunosuppressive treatment in patients after kidney transplantation. | 2016 Oct 1 |
2 |
| 12 |
25975003 | Development and validation of a rapid and reliable real-time PCR method for CYP3A5 genotyping. | 2015 |
1 |
| 13 |
25976223 | CYP3A4∗18B and CYP3A5∗3 polymorphisms contribute to pharmacokinetic variability of cyclosporine among healthy Chinese subjects. | 2015 Aug 30 |
2 |
| 14 |
26177348 | Comparison of tacrolimus and cyclosporin A in CYP3A5 expressing Chinese de novo kidney transplant recipients: a 2-year prospective study. | 2015 May |
3 |
| 15 |
26271661 | Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A-status in liver transplant patients. | 2015 Dec |
2 |
| 16 |
24369269 | Successful telaprevir treatment in combination of cyclosporine against recurrence of hepatitis C in the Japanese liver transplant patients. | 2014 |
1 |
| 17 |
24527031 | Cyclosporine and herbal supplement interactions. | 2014 |
1 |
| 18 |
24658827 | The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients. | 2014 Jun |
2 |
| 19 |
24691060 | Association of CYP3A4*18B and CYP3A5*3 polymorphism with cyclosporine-related liver injury in Chinese renal transplant recipients. | 2014 Jun |
2 |
| 20 |
23557867 | CYP3A4/5 polymorphisms affect the blood level of cyclosporine and tacrolimus in Chinese renal transplant recipients. | 2013 Jun |
1 |
| 21 |
21896346 | Polymorphisms in genes that regulate cyclosporine metabolism affect cyclosporine blood levels and clinical outcomes in patients who receive allogeneic hematopoietic stem cell transplantation. | 2012 Jan |
2 |
| 22 |
22205779 | Cyclosporine A- and tacrolimus-mediated inhibition of CYP3A4 and CYP3A5 in vitro. | 2012 Apr |
3 |
| 23 |
22947591 | CYP3A5 polymorphism effect on cyclosporine pharmacokinetics in living donor renal transplant recipients: analysis by population pharmacokinetics. | 2012 Sep |
4 |
| 24 |
23018254 | Impact of CYP3A4*1B and CYP3A5*3 polymorphisms on the pharmacokinetics of cyclosporine and sirolimus in renal transplant recipients. | 2012 Jul-Sep |
4 |
| 25 |
23085740 | Association of CYP3A polymorphisms with the pharmacokinetics of cyclosporine A in early post-renal transplant recipients in China. | 2012 Dec |
3 |
| 26 |
23217392 | CYP3A4 genetic polymorphisms predict cyclosporine-related clinical events in Chinese renal transplant recipients. | 2012 Dec |
1 |
| 27 |
20368718 | The effect of CYP3A5 polymorphism on dose-adjusted cyclosporine concentration in renal transplant recipients: a meta-analysis. | 2011 Jun |
2 |
| 28 |
21102498 | Cytochrome P450 genetic polymorphisms influence the serum concentration of calcineurin inhibitors in allogeneic hematopoietic SCT recipients. | 2011 Aug |
1 |
| 29 |
21383650 | Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are not associated with cyclosporine pharmacokinetics nor with cyclosporine clinical end points after renal transplantation. | 2011 Apr |
2 |
| 30 |
21806386 | Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients. | 2011 Sep |
2 |
| 31 |
21839244 | Pharmacogenetic study of ABCB1 and CYP3A5 genes during the first year following heart transplantation regarding tacrolimus or cyclosporine levels. | 2011 Jul-Aug |
2 |
| 32 |
21857093 | Influence of ABCB1, CYP3A4*18B and CYP3A5*3 polymorphisms on cyclosporine A pharmacokinetics in bone marrow transplant recipients. | 2011 |
3 |
| 33 |
20170205 | Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I. | 2010 Mar |
2 |
| 34 |
20214406 | Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II. | 2010 Apr |
1 |
| 35 |
20588203 | Effects of the CYP3A5*3 variant on cyclosporine exposure and acute rejection rate in renal transplant patients: a meta-analysis. | 2010 Sep |
2 |
| 36 |
18936931 | Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem. | 2009 Mar |
1 |
| 37 |
19343327 | Impact of CYP3A5 and CYP3A4 gene polymorphisms on dose requirement of calcineurin inhibitors, cyclosporine and tacrolimus, in renal allograft recipients of North India. | 2009 Aug |
1 |
| 38 |
19376366 | Genetic polymorphisms in CYP3A5 and MDR1 genes and their correlations with plasma levels of tacrolimus and cyclosporine in renal transplant recipients. | 2009 Apr |
1 |
| 39 |
19667964 | Pharmacogenetics of calcineurin inhibitors in renal transplantation. | 2009 Aug 15 |
1 |
| 40 |
19925383 | Influence of the MDR1 haplotype and CYP3A5 genotypes on cyclosporine blood level in Chinese renal transplant recipients. | 2009 Dec |
3 |
| 41 |
20038391 | [Pharmacogenetic analysis of the absorption kinetics of cyclosporine in a population of Spanish cardiac transplant patients]. | 2009 Nov-Dec |
1 |
| 42 |
18180803 | CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporine. | 2008 Dec |
2 |
| 43 |
18518855 | A drug transporter for all ages? ABCB1 and the developmental pharmacogenetics of cyclosporine. | 2008 Jun |
1 |
| 44 |
18589174 | Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients. | 2008 Jun |
2 |
| 45 |
18636247 | Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients. | 2008 Nov |
2 |
| 46 |
18978522 | CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients. | 2008 Dec |
4 |
| 47 |
19005401 | Haplotypic structure of ABCB1/MDR1 gene modifies the risk of the acute allograft rejection in renal transplant recipients. | 2008 Nov 15 |
1 |
| 48 |
17151193 | Metabolism of sirolimus in the presence or absence of cyclosporine by genotyped human liver microsomes and recombinant cytochromes P450 3A4 and 3A5. | 2007 Mar |
1 |
| 49 |
17425754 | Multi-drug resistance gene-1 (MDR-1) haplotypes and the CYP3A5*1 genotype have no influence on ciclosporin dose requirements as assessed by C0 or C2 measurements. | 2007 Mar-Apr |
1 |
| 50 |
18240909 | Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update. | 2007 Jul |
1 |